Cascade Bancorp (CACB) Stock Price, News & Analysis

Company Overview

Cascade Bancorp is a United States-based bank holding company. The Company operates through its subsidiary, Bank of the Cascades (the Bank). The Bank is an Oregon state chartered bank. The Bank offers a range of commercial and retail banking services to its customers. It provides commercial real estate loans, real estate construction and development loans, and commercial and industrial loans, as well as consumer installment, line-of-credit, credit card and home equity loans. It also originates residential mortgage loans. It provides consumer and business deposit services, including checking, money market, time deposit accounts and related payment services, Internet banking, electronic bill payment and remote deposits. It provides trust and investment related services. As of December 31, 2015, the Bank operated 37 branches serving communities in Central, Southern and Northwest Oregon, as well as in the greater Boise/Treasure Valley, Idaho and Seattle, Washington areas.

Key Stats

• Today's Range: $6.99 to $6.99
• 50-Day Range: N/A
• 52-Week Range: $5.27 to $8.52
• Volume: N/A
• Average Volume: 150,754 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CACB Stock Analysis - Frequently Asked Questions

How were Cascade Bancorp's earnings last quarter?

Cascade Bancorp (NASDAQ:CACB) announced its earnings results on Tuesday, April, 25th. The financial services provider reported $0.09 EPS for the quarter, topping the consensus estimate of $0.09 by $0.00. The financial services provider earned $32.34 million during the quarter, compared to the consensus estimate of $33.88 million.

What other stocks do shareholders of Cascade Bancorp own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cascade Bancorp investors own include Avon Products (AVP), Sprott Focus Trust (FUND), (MY) (MY), Meta Platforms (META), ETFMG Alternative Harvest ETF (MJX) and NovaBay Pharmaceuticals (NBY).

Company Calendar

• Last Earnings: 4/25/2017
• Today: 5/27/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Regional Banks
• Current Symbol: NASDAQ:CACB
• CIK: 865911
• Web: www.snl.com
• Phone: +1-541-3856205
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A